| Total Critical | Critical Females | Females with No Riska | Females +1 Risk | Females + ≥2 Risk | Critical Males | Males with No Risk | Males +1 Risk | Males + ≥2 Risk | |
n | 579 | 314 | 42 | 81 | 191 | 265 | 45 | 88 | 132 | |
# of Follow-Ups | 355 | 184 | 21 | 48 | 115 | 171 | 26 | 57 | 88 | |
Age Range | 47 - 99 | 50 - 99 | 52 - 95 | 50 - 92 | 52 - 99 | 47 - 98 | 54 - 98 | 47 - 90 | 49 - 93 | |
Age Mean | 72.1 | 71.7 | 70.6 | 71.3 | 71.7 | 72.7 | 74.6 | 71.4 | 73 | |
Age Median | 72 | 72 | 69 | 72 | 72 | 73 | 77 | 71 | 73 | |
<50 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | |
50 - 59 | 48 | 26 | 6 | 9 | 11 | 22 | 3 | 9 | 10 | |
60 - 79 | 394 | 220 | 27 | 53 | 140 | 174 | 29 | 62 | 83 | |
≥80 | 135 | 68 | 9 | 19 | 40 | 67 | 13 | 16 | 38 | |
BMI Range | 17.18 - 74.53 (n = 559) | 17.18 - 74.53 (n = 305) | 17.57 - 47.46 (n = 40) | 17.18 - 43.23 (n = 81) | 18.35 - 74.53 (n = 184) | 18.30 - 55.06 (n = 254) | 23.83 - 50.46 (n = 42) | 18.3 - 52.72 (n = 87) | 19.66 - 55.06 (n = 125) | |
BMI Mean | 32.4 | 31.07 | 28.8 | 29.56 | 32.25 | 33.98 | 32.55 | 33.92 | 34.51 | |
BMI Median | 31.44 | 29.97 | 27.6 | 28.48 | 30.86 | 33.09 | 31.96 | 33.15 | 34.17 | |
Carotid Findings | ||||||||||
Bilateral Critical | 24 | 13 | 3 | 2 | 8 | 11 | 2 | 2 | 7 | |
Left Critical | 268 | 135 | 19 | 32 | 84 | 133 | 20 | 47 | 66 | |
Right Critical | 287 | 166 | 19 | 48 | 99 | 121 | 23 | 39 | 59 | |
Self-Reported Patient Characteristics | ||||||||||
Statins Used | 271 | 142 | 4 | 23 | 115 | 129 | 6 | 29 | 94 | |
History TIA/CVA | 60 | 29 | 2 | 10 | 17 | 31 | 1 | 10 | 20 | |
Afib Reported | 88 | 49 | 0 | 3 | 46 | 39 | 0 | 5 | 34 | |
Hypertension | 403 | 229 | 0 | 44 | 185 | 174 | 0 | 52 | 122 | |
High Cholesterol | 335 | 200 | 0 | 34 | 166 | 135 | 0 | 22 | 113 | |
Diabetes | 116 | 61 | 0 | 1 | 60 | 55 | 0 | 9 | 46 | |